ArticleBlood advances2019
Patients with FLT3-mutant AML needed to enroll on FLT3-targeted therapeutic clinical trials.
Taylor Bucy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleBlood advances2019
Taylor Bucy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.